MedTrace Logo

Hypnotics to Improve Polysomnography Yield: Eszopiclone vs Ramelteon?

NCT00811746 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2013-05-30

No results posted yet for this study

Summary

This study is being conducted to determine if eszopiclone is as effective as ramelteon when used as a pre-medication (sleeping pill) in sleep studies performed to diagnose and treat sleep apnea.

Conditions

Interventions

DRUG

Rozerem (Ramelteon)

8 mg taken orally 30 minutes before a split-night PSG

DRUG

Lunesta (Eszopiclone)

3 mg taken orally 30 minutes before the start of a split-night PSG

OTHER

Historical Controls

Chart review matched for demographics and comorbidities of the study drug groups.

Sponsors & Collaborators

  • Southern California Institute for Research and Education

    lead OTHER

Principal Investigators

  • Catherine S. Sassoon, MD · VA Long Beach Healthcare System

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2010-09-30
Completion
2010-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00811746 on ClinicalTrials.gov